Product development to ensure dose efficacy has come a long way and advances in pharmaceutical sciences & regulations need proven bioavailability / bioequivalence studies for the drug product to be approved for market.
But are patients getting the right dose ? A report by CBS news questions - Are obese cancer patients getting chemotherapy doses too small for them ? Read on...
http://www.cbsnews.com/8301-204_162-57603715/are-obese-people-with-cancer-getting-chemotherapy-doses-too-small-for-them/
It seems organizations must compulsorily have a post-marketing surveillance / Pharmacovigilance strategy that monitors dosing offered to patients as well ??
But are patients getting the right dose ? A report by CBS news questions - Are obese cancer patients getting chemotherapy doses too small for them ? Read on...
http://www.cbsnews.com/8301-204_162-57603715/are-obese-people-with-cancer-getting-chemotherapy-doses-too-small-for-them/
It seems organizations must compulsorily have a post-marketing surveillance / Pharmacovigilance strategy that monitors dosing offered to patients as well ??
